Optimizing patient access for novel stem cell therapy

Optimizing patient access for novel stem cell therapy

Goal

Understand the Funds Flow at national and local level for a haematopoietic stem cell (HSC) therapy in terms of processes, stakeholders and data requirements in order to accelerate the preparation for the launch of the HSC therapy through the definition of a targeted action plan to ensure optimal access.

Approach

Current fund flow

Analyze funds flow for stem cell therapy through primary market research

Analogue learnings

Learn from a Stem Cell analogues

Strategic implications

Define strategic implications & recommendations

  • Derived strategic implications for the preparation of successful HSC therapy patient access
  • Defined the optimal funding scenario for HSC therapy and recommendations on strategies and key actions to maximize optimal patient access likelihood

Learn more about this service

Lifecycle Management

Contact our experts

Philippe Coune

Philippe Coune

Director

mail_icon linkedin_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK